English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 72 | Tables: 80 | Medical Care
The global market for Lung Cancer PCR Panel was valued at US$ 542 million in the year 2024 and is projected to reach a revised size of US$ 829 million by 2031, growing at a CAGR of 6.1% during the forecast period.
A Lung Cancer PCR Panel is a molecular diagnostic tool that uses polymerase chain reaction (PCR) technology to simultaneously detect multiple gene mutations or fusions associated with lung cancer. This panel typically includes key genes such as EGFR, KRAS, ALK, ROS1, and BRAF, which are crucial for understanding tumor biology, guiding targeted therapy, and predicting prognosis. By analyzing DNA or RNA extracted from tumor tissue or liquid biopsy samples, the PCR panel provides rapid and highly sensitive results, aiding in the selection of personalized treatment strategies. Due to its speed, sensitivity, and minimal sample requirements, the Lung Cancer PCR Panel has become an essential component in the clinical management of lung cancer, including diagnosis, treatment planning, and disease monitoring.
North American market for Lung Cancer PCR Panel is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lung Cancer PCR Panel is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lung Cancer PCR Panel in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lung Cancer PCR Panel include Thermo Fisher Scientific, Roche, Qiagen, Bio-Rad Laboratories, Guardant Health, Illumina, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer PCR Panel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer PCR Panel.
The Lung Cancer PCR Panel market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer PCR Panel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer PCR Panel companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Qiagen
Bio-Rad Laboratories
Guardant Health
Illumina
Segment by Type
NGS
Liquid Biopsy
Other
Segment by Application
Hospital
Third-party Independent Laboratory
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer PCR Panel company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer PCR Panel Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NGS
1.2.3 Liquid Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Lung Cancer PCR Panel Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-party Independent Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer PCR Panel Market Perspective (2020-2031)
2.2 Global Lung Cancer PCR Panel Growth Trends by Region
2.2.1 Global Lung Cancer PCR Panel Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lung Cancer PCR Panel Historic Market Size by Region (2020-2025)
2.2.3 Lung Cancer PCR Panel Forecasted Market Size by Region (2026-2031)
2.3 Lung Cancer PCR Panel Market Dynamics
2.3.1 Lung Cancer PCR Panel Industry Trends
2.3.2 Lung Cancer PCR Panel Market Drivers
2.3.3 Lung Cancer PCR Panel Market Challenges
2.3.4 Lung Cancer PCR Panel Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer PCR Panel Players by Revenue
3.1.1 Global Top Lung Cancer PCR Panel Players by Revenue (2020-2025)
3.1.2 Global Lung Cancer PCR Panel Revenue Market Share by Players (2020-2025)
3.2 Global Top Lung Cancer PCR Panel Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lung Cancer PCR Panel Revenue
3.4 Global Lung Cancer PCR Panel Market Concentration Ratio
3.4.1 Global Lung Cancer PCR Panel Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer PCR Panel Revenue in 2024
3.5 Global Key Players of Lung Cancer PCR Panel Head office and Area Served
3.6 Global Key Players of Lung Cancer PCR Panel, Product and Application
3.7 Global Key Players of Lung Cancer PCR Panel, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer PCR Panel Breakdown Data by Type
4.1 Global Lung Cancer PCR Panel Historic Market Size by Type (2020-2025)
4.2 Global Lung Cancer PCR Panel Forecasted Market Size by Type (2026-2031)
5 Lung Cancer PCR Panel Breakdown Data by Application
5.1 Global Lung Cancer PCR Panel Historic Market Size by Application (2020-2025)
5.2 Global Lung Cancer PCR Panel Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lung Cancer PCR Panel Market Size (2020-2031)
6.2 North America Lung Cancer PCR Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lung Cancer PCR Panel Market Size by Country (2020-2025)
6.4 North America Lung Cancer PCR Panel Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer PCR Panel Market Size (2020-2031)
7.2 Europe Lung Cancer PCR Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lung Cancer PCR Panel Market Size by Country (2020-2025)
7.4 Europe Lung Cancer PCR Panel Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer PCR Panel Market Size (2020-2031)
8.2 Asia-Pacific Lung Cancer PCR Panel Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lung Cancer PCR Panel Market Size by Region (2020-2025)
8.4 Asia-Pacific Lung Cancer PCR Panel Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer PCR Panel Market Size (2020-2031)
9.2 Latin America Lung Cancer PCR Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lung Cancer PCR Panel Market Size by Country (2020-2025)
9.4 Latin America Lung Cancer PCR Panel Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer PCR Panel Market Size (2020-2031)
10.2 Middle East & Africa Lung Cancer PCR Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lung Cancer PCR Panel Market Size by Country (2020-2025)
10.4 Middle East & Africa Lung Cancer PCR Panel Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Lung Cancer PCR Panel Introduction
11.1.4 Thermo Fisher Scientific Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Lung Cancer PCR Panel Introduction
11.2.4 Roche Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer PCR Panel Introduction
11.3.4 Qiagen Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.3.5 Qiagen Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Lung Cancer PCR Panel Introduction
11.4.4 Bio-Rad Laboratories Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Details
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Lung Cancer PCR Panel Introduction
11.5.4 Guardant Health Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.5.5 Guardant Health Recent Development
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Lung Cancer PCR Panel Introduction
11.6.4 Illumina Revenue in Lung Cancer PCR Panel Business (2020-2025)
11.6.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lung Cancer PCR Panel Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NGS
Table 3. Key Players of Liquid Biopsy
Table 4. Key Players of Other
Table 5. Global Lung Cancer PCR Panel Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Lung Cancer PCR Panel Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lung Cancer PCR Panel Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Lung Cancer PCR Panel Market Share by Region (2020-2025)
Table 9. Global Lung Cancer PCR Panel Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Lung Cancer PCR Panel Market Share by Region (2026-2031)
Table 11. Lung Cancer PCR Panel Market Trends
Table 12. Lung Cancer PCR Panel Market Drivers
Table 13. Lung Cancer PCR Panel Market Challenges
Table 14. Lung Cancer PCR Panel Market Restraints
Table 15. Global Lung Cancer PCR Panel Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Lung Cancer PCR Panel Market Share by Players (2020-2025)
Table 17. Global Top Lung Cancer PCR Panel Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer PCR Panel as of 2024)
Table 18. Ranking of Global Top Lung Cancer PCR Panel Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Lung Cancer PCR Panel Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Lung Cancer PCR Panel, Headquarters and Area Served
Table 21. Global Key Players of Lung Cancer PCR Panel, Product and Application
Table 22. Global Key Players of Lung Cancer PCR Panel, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lung Cancer PCR Panel Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Lung Cancer PCR Panel Revenue Market Share by Type (2020-2025)
Table 26. Global Lung Cancer PCR Panel Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Lung Cancer PCR Panel Revenue Market Share by Type (2026-2031)
Table 28. Global Lung Cancer PCR Panel Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Lung Cancer PCR Panel Revenue Market Share by Application (2020-2025)
Table 30. Global Lung Cancer PCR Panel Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Lung Cancer PCR Panel Revenue Market Share by Application (2026-2031)
Table 32. North America Lung Cancer PCR Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Lung Cancer PCR Panel Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Lung Cancer PCR Panel Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Lung Cancer PCR Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Lung Cancer PCR Panel Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Lung Cancer PCR Panel Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Lung Cancer PCR Panel Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Lung Cancer PCR Panel Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Lung Cancer PCR Panel Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Lung Cancer PCR Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Lung Cancer PCR Panel Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Lung Cancer PCR Panel Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Lung Cancer PCR Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Lung Cancer PCR Panel Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Lung Cancer PCR Panel Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Lung Cancer PCR Panel Product
Table 50. Thermo Fisher Scientific Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche Lung Cancer PCR Panel Product
Table 55. Roche Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Qiagen Company Details
Table 58. Qiagen Business Overview
Table 59. Qiagen Lung Cancer PCR Panel Product
Table 60. Qiagen Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 61. Qiagen Recent Development
Table 62. Bio-Rad Laboratories Company Details
Table 63. Bio-Rad Laboratories Business Overview
Table 64. Bio-Rad Laboratories Lung Cancer PCR Panel Product
Table 65. Bio-Rad Laboratories Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 66. Bio-Rad Laboratories Recent Development
Table 67. Guardant Health Company Details
Table 68. Guardant Health Business Overview
Table 69. Guardant Health Lung Cancer PCR Panel Product
Table 70. Guardant Health Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 71. Guardant Health Recent Development
Table 72. Illumina Company Details
Table 73. Illumina Business Overview
Table 74. Illumina Lung Cancer PCR Panel Product
Table 75. Illumina Revenue in Lung Cancer PCR Panel Business (2020-2025) & (US$ Million)
Table 76. Illumina Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Lung Cancer PCR Panel Picture
Figure 2. Global Lung Cancer PCR Panel Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lung Cancer PCR Panel Market Share by Type: 2024 VS 2031
Figure 4. NGS Features
Figure 5. Liquid Biopsy Features
Figure 6. Other Features
Figure 7. Global Lung Cancer PCR Panel Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Lung Cancer PCR Panel Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Third-party Independent Laboratory Case Studies
Figure 11. Other Case Studies
Figure 12. Lung Cancer PCR Panel Report Years Considered
Figure 13. Global Lung Cancer PCR Panel Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Lung Cancer PCR Panel Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Lung Cancer PCR Panel Market Share by Region: 2024 VS 2031
Figure 16. Global Lung Cancer PCR Panel Market Share by Players in 2024
Figure 17. Global Lung Cancer PCR Panel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer PCR Panel Revenue in 2024
Figure 19. North America Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Lung Cancer PCR Panel Market Share by Country (2020-2031)
Figure 21. United States Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lung Cancer PCR Panel Market Share by Country (2020-2031)
Figure 25. Germany Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lung Cancer PCR Panel Market Share by Region (2020-2031)
Figure 33. China Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lung Cancer PCR Panel Market Share by Country (2020-2031)
Figure 41. Mexico Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lung Cancer PCR Panel Market Share by Country (2020-2031)
Figure 45. Turkey Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Lung Cancer PCR Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 50. Qiagen Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 52. Guardant Health Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in Lung Cancer PCR Panel Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
